TABLE 2.
The signals of AEs of pirfenidone at the SOC level in the FEARS database.
| SOC name | Case number | PT | Percentage (%) |
|---|---|---|---|
| Gastrointestinal disorders | 9,927 | 21 | 30.63 |
| General disorders and administration site conditions | 8,009 | 8 | 24.71 |
| Respiratory, thoracic and mediastinal disorders | 4,694 | 44 | 14.48 |
| Metabolism and nutrition disorders | 2,168 | 7 | 6.69 |
| Skin and subcutaneous tissue disorders | 1969 | 9 | 6.08 |
| Investigations | 1925 | 21 | 5.94 |
| Cardiac disorders | 1,343 | 6 | 4.14 |
| Psychiatric disorders | 759 | 5 | 2.34 |
| Injury, poisoning and procedural complications | 748 | 6 | 2.31 |
| Nervous system disorders | 406 | 4 | 1.25 |
| Immune system disorders | 228 | 2 | 0.70 |
| Renal and urinary disorders | 69 | 1 | 0.21 |
| Vascular disorders | 66 | 5 | 0.20 |
| Surgical and medical procedures | 66 | 5 | 0.20 |
| Social circumstances | 14 | 1 | 0.04 |
| Musculoskeletal and connective tissue disorders | 8 | 1 | 0.02 |
| Reproductive system and breast disorders | 6 | 2 | 0.02 |
| Infections and infestations | 3 | 1 | 0.01 |
| Ear and labyrinth disorders | 3 | 1 | 0.01 |
Abbreviations: AEs, adverse events; SOC, system organ class; FAERS, food and drug administration adverse event reporting system; PT, preferred term.